Trial intelligence / Profile preview

Microneedling and PDT for Facial Actinic Keratoses

NCT02622594Phase 4Completed

Sponsor
Dermatology, Laser & Vein Specialists of the Carolinas
Start
Oct 2015
Primary completion
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of 5-aminolevulinic acid in actinic keratosis (AK), sponsored by Dermatology, Laser & Vein Specialists of the Carolinas. Started Oct 2015; status: completed.

02

Drugs

5-aminolevulinic acid
03

Conditions

actinic keratosis (AK)

Beyond the preview

Go deeper on NCT02622594.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02622594.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call